Stocktwits on MSN

MannKind rallies on optimism of two imminent product launches: Analyst sees 'multiple headwinds' for stock in 2026

H.C. Wainwright reiterated a ‘Buy’ rating on MannKind with an $11 price target after the company’s update. ・The firm said it ...
Yahoo Finance

TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation Powder

FORT WORTH, Texas, April 19, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug ...
Monthly Prescribing Reference

ProAir Digihaler, a Rescue Inhaler With Built-In Sensors, Now Available

ProAir Digihaler ProAir® Digihaler® (albuterol sulfate; Teva) Inhalation Powder is now available for patients aged ≥4 years for the treatment or prevention of bronchospasm with reversible obstructive ...
Seeking Alpha

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with ...

MORRISVILLE, N.C., May 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation, a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today ...

MannKind Provides Business Updates and 2026 Growth Drivers

MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

Transpire Bio Announces Completion of First Human Dosing in Clinical Trial Using its Novel Inhalation Formulation

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...
Business Wire

Teva Announces Availability of ProAir ® Digihaler ® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD

- First and Only Digital Rescue Inhaler with Built-In Sensors Now Available By Prescription to Patients in the U.S. TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC., a U.S.
Monthly Prescribing Reference

Inbrija Inhalation Powder Approved for Parkinson’s Disease

inbrija-1 Inbrija (levodopa inhalation powder; Acorda Therapeutics) is the first and only FDA-approved inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease ...
Medscape

New FDA Orphan Drugs: Amphotericin B Inhalation Powder, TRX4, AT2101

March 2, 2006 — The US Food and Drug Administration (FDA) has approved orphan drug status for amphotericin B inhalation powder in the prevention of pulmonary fungal infections in patients at risk for ...
Business Wire

Teva Launches Two Digital Inhalers in the U.S., AirDuo ® Digihaler ® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir ® Digihaler ® (fluticasone ...

TEL AVIV, ISRAEL & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AirDuo ® ...
manilatimes

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with ...

FDA's approval of YUTREPIA paves the way for prescribers to add a new treatment option for patients with PAH and PH-ILD YUTREPIA is designed to enhance deep-lung delivery with an easy-to-use device ...